Free Trial

Nebula Research & Development LLC Acquires Shares of 6,123 Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Nebula Research & Development LLC bought a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 6,123 shares of the company's stock, valued at approximately $1,782,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Versant Capital Management Inc grew its stake in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after purchasing an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare in the 4th quarter valued at $52,000. Hurley Capital LLC purchased a new stake in Molina Healthcare in the 4th quarter valued at $55,000. EverSource Wealth Advisors LLC boosted its stake in Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. grew its position in Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after purchasing an additional 155 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of recent research reports. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Truist Financial raised their target price on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Baird R W lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays lifted their price objective on Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a report on Friday, April 25th. Finally, Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and an average price target of $365.38.

View Our Latest Stock Report on MOH

Molina Healthcare Stock Performance

Shares of NYSE MOH traded down $8.09 during trading on Thursday, reaching $318.92. The stock had a trading volume of 265,479 shares, compared to its average volume of 674,392. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock has a market cap of $17.44 billion, a PE ratio of 15.61, a P/E/G ratio of 1.06 and a beta of 0.70. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $365.23. The firm's 50 day moving average price is $321.51 and its two-hundred day moving average price is $307.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the prior year, the company earned $5.73 earnings per share. The firm's revenue was up 12.2% compared to the same quarter last year. On average, research analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.10% of the stock is currently owned by insiders.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Recommended Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines